cbdMD (NYSEAMERICAN:YCBD) Stock Price Down 3.4% – Should You Sell?

cbdMD, Inc. (NYSEAMERICAN:YCBD) shares traded down 3.4% on Wednesday. The company traded as low as $0.4408 and last traded at $0.4530. Approximately 87,295 shares changed hands during mid-day trading, a decline of 91% from the average session volume of 983,580 shares. The stock had previously closed at $0.4690.

Wall Street Analysts Forecast Growth

Separately, Maxim Group downgraded shares of cbdMD from a “buy” rating to a “hold” rating in a research note on Monday, August 17th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

cbdMD Stock Up 1.2%

The stock has a fifty day moving average of $0.50 and a 200-day moving average of $0.66.

cbdMD (NYSEAMERICAN:YCBD) last posted its earnings results on Thursday, August 13th. The company reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.08). The firm had revenue of $5.55 million for the quarter, compared to analyst estimates of $5.69 million. cbdMD had a negative return on equity of 34.26% and a negative net margin of 13.80%.

About cbdMD

cbdMD is a consumer health and wellness company that develops, markets and sells cannabidiol (CBD) products. Its product portfolio has included CBD gummies, tinctures, capsules, softgels, beverages, creams, balms and other topical products designed for general wellness and everyday use.

The company has also marketed pet-focused CBD products through its Paw CBD brand. cbdMD has primarily served customers in the United States through its e-commerce platforms, with products also available through select retail and distribution channels.